| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Endoluminal Sciences is an early stage venture capital-backed company, committed to the development of novel, platform technologies to dramatically enhance the clinical performance of endovascular prostheses. While the technology is foreseen to have its application to a range of vascular disease states, the immediate focus is the treatment of abdominal aortic aneurysms (AAAs). |
| Category: | Health & biotech |
| URL: | http://www.endoluminalsciences.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | Eveleigh, Sydney, NSW 2015 |
| State: | New South Wales |
| Overseas Operations: | No |
| Twitter: | Tweets by @endoluminal |
| Facebook: | |
| Linkedin: | |
| Founders: |
No items found
|
| Awards won: | |
